60dayCorrection

51273

Federal Register / Vol. 75, No. 160 / Thursday, August 19, 2010 / Notices
A.12–1—ESTIMATES OF NET HOUR BURDEN REDUCTION
Type of
respondents

Number of
respondents

Stage 1: Immediate .........................................................................
Stage 1: Expected Reduction in Current burden (assuming 100
universities and at median) ..........................................................
Net reduction in burden ...................................................................
Stage 1: Future ................................................................................
Stage 2: Expected Reduction in Current burden (assuming 100
universities and at median) ..........................................................
Net reduction in burden ...................................................................

Request for Comments: Written
comments and/or suggestions from the
public and affected agencies should
address one or more of the following
points: (1) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) Evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and (4) Minimize the burden
of the collection of information on those
who are to respond, including the use
of appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
FOR FURTHER INFORMATION CONTACT:

To

emcdonald on DSK2BSOYB1PROD with NOTICES

request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Dr. Stefano
Bertuzzi, Health Science Policy Analyst,
Office of Science and Technology
Policy, OSP, OD; NIH, Building 1, Room
218, 9000 Rockville Pike, Bethesda, MD
20892 or call non-toll-free number 301–
495–9286 or e-mail your request,
including your address to:
[email protected].
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Dated: August 12, 2010.
Lynn D. Hudson,
Director, Office of Science Policy Analysis,
National Institutes of Health.

1

72

+7,200

100
100
100

4
4
4

40
............................
1.0

¥16,000
¥8,800
+400

100
100

4
4

40
............................

¥16,000
¥15,600

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day-10–0798]

Proposed Data Collections Submitted
for Public Comment and
Recommendations; Correction
Centers for Disease Control and
Prevention
Notice; Correction
The Centers for Disease Control and
Prevention published a document in the
Federal Register titled 60-day 10–0798.
The document contained the incorrect
OMB number and expiration date.
FOR FURTHER INFORMATION CONTACT:
Maryam Daneshvar, 404–639–4604
Correction
In the Federal Register of August 12,
2010, Volume 75, Number 155, in FR
Doc. 2010–19911 page 48972, under the
Proposed Project paragraph correct
(OMB No. 0920–0753 exp. 10/31/2010)
to read: (OMB No. 0920–0798 exp. 1/31/
2011).
Dated: August 12, 2010.
Maryam I, Daneshvar,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2010–20570 Filed 8–18–10; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention (CDC)

[FR Doc. 2010–20614 Filed 8–18–10; 8:45 am]
BILLING CODE 4140–01–P

AGENCY:

17:05 Aug 18, 2010

Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).

Jkt 220001

PO 00000

Frm 00036

Fmt 4703

Annual hour
burden

100

Expanded Human Immunodeficiency
Virus (HIV) Testing for
Disproportionately Affected
Populations

VerDate Mar<15>2010

Average
time per
response
(in hours)

Frequency of
response

Sfmt 4703

ACTION:

Notice.

Notice of Intent to increase funding
available to make awards under the
Centers for Disease Control and
Prevention Funding Opportunity
Announcement CDC–RFA–PS10–10138,
‘‘Expanded Human Immunodeficiency
Virus (HIV) Testing for
Disproportionately Affected
Populations’’. Additional funding from
the Patient Protection and Affordable
Care Act has been allocated for awards
to state and county and local public
health departments with at least 175
estimated combined AIDS diagnoses
among Blacks/African Americans and
Hispanics/Latinos in 2007.
SUMMARY: This notice provides public
notice of CDC’s intent to increase
available funding for the Centers for
Disease Control and Prevention Funding
Opportunity Announcement PS10–
10138, ‘‘Expanded Human
Immunodeficiency Virus (HIV) Testing
for Disproportionately Affected
Populations’’ to make awards to state
and county and local public health
departments. It is the intent of CDC to
increase the amount of funds available
to applicants who applied for awards
under the previously announced
funding opportunity CDC–RFA–PS10–
10138, which closed on June 24, 2010.
CDC received additional funding
through the Patient Protection
Affordable Care Act (PPACA), Section
4002 Prevention and Public Health
Fund. Accordingly CDC adds the
following information to the previously
published funding opportunity
announcement:
—Catalog of Federal Domestic
Assistance Number: 93.523 The
Affordable Care Act: Human
Immunodeficiency Virus (HIV)
Prevention and Public Health Fund
Activities.
—Authority: This program is authorized
under Sections 301 and 318 of the
Public Health Service Act (42 U.S.C.
Section 241 and 247c), as amended,
and Section 4002 of the Patient

E:\FR\FM\19AUN1.SGM

19AUN1